Additional FDA clearance for
Omadacycline MTS™
Liofilchem has received an additional clearance from the FDA to use in the United States the Omadacycline 0.002-32 μg/mL MTS™ (MIC Test Strip), a quantitative assay for determining the Minimum Inhibitory Concentration (MIC) of Omadacycline, with fastidious organisms.
Omadacycline MTS™ has been shown to be active both clinically and in vitro against Gram-positive and Gram-negative bacteria, including
S. aureus, E. faecalis, S.pneumoniae, S. pyogenes, K. pneumonia, H. influenzae
, and in vitro only against
E. faecium, E. coli, C. freundii.